Related Experiment Video
Updated: May 9, 2026
Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Pediatric lung transplantation in 2026: recent changes and current challenges
Saba Sheikh1, Christian Benden, Gary A Visner
1Division of Pulmonary Medicine, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Insights
Pediatric lung transplantation offers improved survival and quality of life for children with end-stage lung disease. Careful patient selection and evolving techniques enhance outcomes, though further research is needed.
Area of Science:
- Pediatric Pulmonology
- Thoracic Surgery
- Transplant Medicine
Background:
- Lung transplantation is a viable treatment for pediatric end-stage lung disease.
- It significantly improves survival and health-related quality of life (HRQoL).
- Pediatric lung transplantation presents unique complexities compared to adult procedures.
Purpose of the Study:
- Review key aspects of pediatric lung transplantation.
- Share recent advancements in the field.
- Discuss current challenges and future directions.
Main Methods:
- Review of current literature and clinical practices in pediatric lung transplantation.
- Analysis of evolving surgical techniques and post-transplant management strategies.
- Discussion of diagnostic shifts and age-specific considerations.
Main Results:
- Underlying diagnoses for pediatric lung transplantation vary by age and have changed over time.
- Early referral, precise patient selection, and optimal listing timing are critical.
- Surgical methods, organ use, bridging strategies, and complication management are continuously improving long-term survival.
Conclusions:
- Pediatric lung transplantation is successful in improving HRQoL despite inherent challenges.
- Further research is essential for expanding donor availability.
- Enhanced peri-transplant care and improved prevention/treatment of infections and rejection are crucial.
Purpose Of Review:
Lung transplantation has evolved as an accepted therapy in carefully selected children with end-stage lung disease, offering prolonged survival and improved health-related quality of life (HRQoL). Pediatric lung transplantation is complex and multilayered and differs from adult transplant. Specific aspects of pediatric lung transplantation will be reviewed, updates on recent developments in the field will be shared, and current challenges will be discussed.
Recent Findings:
The underlying diagnoses leading to lung transplantation vary considerably by age group and have shifted in the last decade. With children requiring special consideration due to their size and immune status, early referral, careful patient selection, and appropriate timing of listing are crucial. Surgical techniques, donor organ utilization, bridging sick patients to transplant and management of posttransplant complications are continually evolving to improve long term survival.
Summary:
Despite its challenges, lung transplant in pediatrics is successful and can improve HRQoL. Developments and further research in expanding the donor pool, peri-transplant management and prevention and treatment of infectious complications and transplant rejection are needed.
